Skip to content

Opening book details…

About this Medicine article

High rates of durable response are achieved with imatinib after treatment with interferon plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial by Guilhot, F.; Druker, B.; Larson, R. A.; Gathmann, I.; So, C.; Waltzman, R.; O'Brien, S. G. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Guilhot, F.; Druker, B.; Larson, R. A.; Gathmann, I.; So, C.; Waltzman, R.; O'Brien, S. G.
Publisher
Ferrata Storti Foundation; Pavia: Fondazione Ferrata Storti; Ferrata Storti Foundation (Haematologica) (ISSN 0390-6078)
Published
2009
Language
EN
Field
Medicine (Health Sciences)

More by Guilhot, F.; Druker, B.; Larson, R. A.; Gathmann, I.; So, C.; Waltzman, R.; O'Brien, S. G.

Browse all works by Guilhot, F.; Druker, B.; Larson, R. A.; Gathmann, I.; So, C.; Waltzman, R.; O'Brien, S. G.